GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (NAS:MEDP) » Definitions » Cyclically Adjusted PB Ratio

MEDP (Medpace Holdings) Cyclically Adjusted PB Ratio : 14.07 (As of May. 29, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Cyclically Adjusted PB Ratio?

As of today (2025-05-29), Medpace Holdings's current share price is $293.81. Medpace Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $20.88. Medpace Holdings's Cyclically Adjusted PB Ratio for today is 14.07.

The historical rank and industry rank for Medpace Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEDP' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 13.75   Med: 16.68   Max: 22.19
Current: 14.15

During the past years, Medpace Holdings's highest Cyclically Adjusted PB Ratio was 22.19. The lowest was 13.75. And the median was 16.68.

MEDP's Cyclically Adjusted PB Ratio is ranked worse than
94.12% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.845 vs MEDP: 14.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medpace Holdings's adjusted book value per share data for the three months ended in Mar. 2025 was $19.896. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $20.88 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medpace Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medpace Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Cyclically Adjusted PB Ratio Chart

Medpace Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 16.10

Medpace Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20.64 16.48 16.10 14.59

Competitive Comparison of Medpace Holdings's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Medpace Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Cyclically Adjusted PB Ratio falls into.


;
;

Medpace Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medpace Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=293.81/20.88
=14.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Medpace Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=19.896/134.9266*134.9266
=19.896

Current CPI (Mar. 2025) = 134.9266.

Medpace Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 10.433 99.792 14.106
201603 10.541 100.470 14.156
201606 10.661 101.688 14.146
201609 14.995 101.861 19.863
201612 15.019 101.863 19.894
201703 15.266 102.862 20.025
201706 15.301 103.349 19.976
201709 14.711 104.136 19.061
201712 14.197 104.011 18.417
201803 14.394 105.290 18.446
201806 15.194 106.317 19.283
201809 15.775 106.507 19.984
201812 16.534 105.998 21.046
201903 17.406 107.251 21.898
201906 18.333 108.070 22.889
201909 19.216 108.329 23.934
201912 20.138 108.420 25.061
202003 20.229 108.902 25.063
202006 20.845 108.767 25.858
202009 22.139 109.815 27.202
202012 22.685 109.897 27.852
202103 23.908 111.754 28.865
202106 23.783 114.631 27.994
202109 24.989 115.734 29.133
202112 26.465 117.630 30.357
202203 17.979 121.301 19.999
202206 9.141 125.017 9.866
202209 11.251 125.227 12.123
202212 12.427 125.222 13.390
202303 11.340 127.348 12.015
202306 12.795 128.729 13.411
202309 15.348 129.860 15.947
202312 18.176 129.419 18.949
202403 21.675 131.776 22.193
202406 24.631 132.554 25.072
202409 28.359 133.029 28.764
202412 26.951 133.157 27.309
202503 19.896 134.927 19.896

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medpace Holdings  (NAS:MEDP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medpace Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medpace Holdings Business Description

Traded in Other Exchanges
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Executives
Stephen P Ewald officer: General Counsel & Corp. Secy. C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227
Brian T Carley director C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Robert O. Kraft director ONE CVS DRIVE, WOONSOCKET RI 02895
Susan E Burwig officer: Exec. VP, Operations C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
August J. Troendle director, 10 percent owner, officer: CEO 5375 MEDPACE WAY, CINCINNATI OH 45227
Ashley M. Keating director 5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Investors, Llc 10 percent owner 4620 WESLEY AVENUE, CINCINNATI OH 45212
Jesse J Geiger officer: CFO & COO, Lab Operations C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Kevin M. Brady officer: CFO & Treasurer MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Femida H. Gwadry-sridhar director 5375 MEDPACE WAY, CINCINNATI OH 45227
Davenport Fred B Jr director
Mccarthy Cornelius P. Iii director 5375 MEDPACE WAY, CINCINNATI OH 45227
Tom C King director 5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Limited Partnership 10 percent owner EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP
Cinven Capital Management (v) General Partner Ltd 10 percent owner EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP